{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:52:16Z","timestamp":1770742336161,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,24]]},"DOI":"10.7759\/cureus.44037","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T13:36:35Z","timestamp":1692884195000},"source":"Crossref","is-referenced-by-count":4,"title":["Longitudinally Extensive Transverse Myelitis as a First Manifestation of Sarcoidosis"],"prefix":"10.7759","author":[{"given":"Ricardo A","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Telma","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o A","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Argemiro","family":"Geraldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","unstructured":"Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002, 59.499-505. 10.1212\/wnl.59.4.499","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1019132","article-title":"An approach to the diagnosis of acute transverse myelitis","volume":"28","author":"Jacob A","year":"2008","unstructured":"Jacob A, Weinshenker BG. An approach to the diagnosis of acute transverse myelitis. Semin Neurol. 2008, 28:105-20. 10.1055\/s-2007-1019132","journal-title":"Semin Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8092-5","article-title":"Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients","volume":"263","author":"Durel CA","year":"2016","unstructured":"Durel CA, Marignier R, Maucort-Boulch D, et al.. Clinical features and prognostic factors of spinal cord sarcoidosis: a multicenter observational study of 20 BIOPSY-PROVEN patients. J Neurol. 2016, 263:981-90. 10.1007\/s00415-016-8092-5","journal-title":"J Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.05.055","article-title":"Neurosarcoidosis according to Zajicek and Scolding criteria: 15 probable and definite cases, their treatment and outcomes","volume":"379","author":"Ca\u00e7\u00e3o G","year":"2017","unstructured":"Ca\u00e7\u00e3o G, Branco A, Meireles M, Alves JE, Mateus A, Silva AM, Santos E. Neurosarcoidosis according to Zajicek and Scolding criteria: 15 probable and definite cases, their treatment and outcomes. J Neurol Sci. 2017, 379:84-8. 10.1016\/j.jns.2017.05.055","journal-title":"J Neurol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2019.04.006","article-title":"Clinical manifestations, diagnosis, and treatment of sarcoidosis","volume":"3","author":"Ungprasert P","year":"2019","unstructured":"Ungprasert P, Ryu JH, Matteson EL. Clinical manifestations, diagnosis, and treatment of sarcoidosis. Mayo Clin Proc Innov Qual Outcomes. 2019, 3:358-75. 10.1016\/j.mayocpiqo.2019.04.006","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2017-001845","article-title":"A practical approach to the diagnosis of spinal cord lesions","volume":"18","author":"Mariano R","year":"2018","unstructured":"Mariano R, Flanagan EP, Weinshenker BG, Palace J. A practical approach to the diagnosis of spinal cord lesions. Pract Neurol. 2018, 18:187-200. 10.1136\/practneurol-2017-001845","journal-title":"Pract Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0741-x","article-title":"Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis","volume":"16","author":"Fritz D","year":"2016","unstructured":"Fritz D, van de Beek D, Brouwer MC. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol. 2016, 16:220. 10.1186\/s12883-016-0741-x","journal-title":"BMC Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0b013e31819bcf84","article-title":"Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis","volume":"15","author":"Khoury J","year":"2009","unstructured":"Khoury J, Wellik KE, Demaerschalk BM, Wingerchuk DM. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist. 2009, 15:108-11. 10.1097\/NRL.0b013e31819bcf84","journal-title":"Neurologist"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1515\/tnsci-2022-0231","article-title":"Neurosarcoidosis presenting as longitudinally extensive myelitis: diagnostic assessment, differential diagnosis, and therapeutic approach","volume":"13","author":"Cicia A","year":"2022","unstructured":"Cicia A, Nociti V, Bianco A, De Fino C, Carlomagno V, Mirabella M, Lucchini M. Neurosarcoidosis presenting as longitudinally extensive myelitis: diagnostic assessment, differential diagnosis, and therapeutic approach. Transl Neurosci. 2022, 13:191-7. 10.1515\/tnsci-2022-0231","journal-title":"Transl Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002992","article-title":"Central canal enhancement and the trident sign in spinal cord sarcoidosis","volume":"87","author":"Zalewski NL","year":"2016","unstructured":"Zalewski NL, Krecke KN, Weinshenker BG, Aksamit AJ, Conway BL, McKeon A, Flanagan EP. Central canal enhancement and the trident sign in spinal cord sarcoidosis. Neurology. 2016, 87:743-4. 10.1212\/WNL.0000000000002992","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003431","article-title":"Treatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetil","volume":"87","author":"Bitoun S","year":"2016","unstructured":"Bitoun S, Bouvry D, Borie R, et al.. Treatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetil. Neurology. 2016, 87:2517-21. 10.1212\/WNL.0000000000003431","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000341278.26993.22","article-title":"Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil","volume":"72","author":"Moravan M","year":"2009","unstructured":"Moravan M, Segal BM. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology. 2009, 72:337-40. 10.1212\/01.wnl.0000341278.26993.22","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/178800-longitudinally-extensive-transverse-myelitis-as-a-first-manifestation-of-sarcoidosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:45Z","timestamp":1707508545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/178800-longitudinally-extensive-transverse-myelitis-as-a-first-manifestation-of-sarcoidosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.44037","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}